Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/27/2013 | CN102477426B Separated nucleotide molecule and application thereof in bunia virus detection |
11/27/2013 | CN102399791B Cotton ghNAC3 transcription factor gene and application thereof |
11/27/2013 | CN102323400B Method for detecting and identifying variety of snake venom by utilizing adaptor technology |
11/27/2013 | CN102209784B Periostin-induced pancreatic regeneration |
11/27/2013 | CN102206645B Mediating method of RNAi (ribonucleic acid interference) utilizing lentiviral vector |
11/27/2013 | CN102140132B Anther development control gene and application thereof to male sterility of arabidopsis |
11/27/2013 | CN102140131B Anther development control gene and use thereof in realizing male sterility in Arabidopsis thaliana |
11/27/2013 | CN102120763B Rice osnac coding sequence and application thereof |
11/27/2013 | CN102016031B Identification of hypertension susceptibility gene group |
11/27/2013 | CN101955961B Gene knockout targeting vector and application thereof |
11/27/2013 | CN101824427B Method for preparing phycoerythrin-phycocyanin protein alpha subunit fluorescent protein combined with phycourobilin through molecule design |
11/27/2013 | CN101248182B Corn plants and seed enhanced for asparagine and protein |
11/27/2013 | CN101228277B Yield increase in plants overexpressing ACCDP genes |
11/26/2013 | US8594940 System and method for analyzing chromosomal states based on gene expression |
11/26/2013 | US8592667 Maize inbred PH18FC |
11/26/2013 | US8592664 Maize variety hybrid X18B745 |
11/26/2013 | US8592663 Tobacco nicotine demethylase genomic clone and uses thereof |
11/26/2013 | US8592662 Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom |
11/26/2013 | US8592661 Citrus cultivar CALLOR1 |
11/26/2013 | US8592660 Soybean cultivar 13430771 |
11/26/2013 | US8592659 Soybean variety XB00N12 |
11/26/2013 | US8592658 Soybean cultivar S100323 |
11/26/2013 | US8592657 Soybean variety XB42C11 |
11/26/2013 | US8592656 Soybean cultivar S070142 |
11/26/2013 | US8592654 Lettuce cultivar gandhi |
11/26/2013 | US8592653 Corn event DAS-59122-7 and methods for detection thereof |
11/26/2013 | US8592652 Use of subtilisin-like RNR9 polynucleotide for achieving pathogen resistance in plants |
11/26/2013 | US8592651 Antimicrobial peptides and uses thereof |
11/26/2013 | US8592650 Elite event EE-GM3 and methods and kits for identifying such event in biological samples |
11/26/2013 | US8592649 Functional expression of shuffled yeast nitrate transporter (YNT1) in maize to improve nitrate uptake under low nitrate environment |
11/26/2013 | US8592648 Seed treatment with combinations of pyrethrins/pyrethroids and thiamethoxam |
11/26/2013 | US8592647 Manipulation of ammonium transporters (AMTs) to improve NUE in higher plants |
11/26/2013 | US8592646 Promoter, promoter control elements, and combinations, and uses thereof |
11/26/2013 | US8592645 Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis |
11/26/2013 | US8592570 Compositions and methods for inhibiting expression of an RNA from West Nile virus |
11/26/2013 | US8592562 Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects |
11/26/2013 | US8592557 Multimeric TNF receptor fusion proteins and nucleic acids encoding same |
11/26/2013 | US8592554 Immunotoxins for the treatment of diseases related to CMV infection |
11/26/2013 | US8592553 Cloned glucagon-like peptide-2 receptors |
11/26/2013 | US8592389 MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes |
11/26/2013 | US8592388 Targeting MicroRNAs for metabolic disorders |
11/26/2013 | US8592387 Methods for treating or preventing heart damage with integrin-linked kinase (ILK) compositions |
11/26/2013 | US8592385 Polymer micelle complex including nucleic acid |
11/26/2013 | US8592384 Micro-RNA's that regulate muscle cells |
11/26/2013 | US8592224 Biochip for archiving and laboratory-medical analysis of biological sample material, process for its production, and its use in diagnostic methods |
11/26/2013 | US8592212 Soybean transformation method |
11/26/2013 | US8592211 Enhanced PiggyBac transposon and methods for transposon mutagenesis |
11/26/2013 | US8592210 Polyarginine-modified liposome having nuclear entry ability |
11/26/2013 | US8592206 Culture based screening assay and methods of use thereof to identify agents which modulate tumor development, invasion and differentiation |
11/26/2013 | US8592205 Replication-defective arenavirus vectors |
11/26/2013 | US8592202 Biosensors for detecting macromolecules and other analytes |
11/26/2013 | US8592194 Glucoamylase variants with altered properties |
11/26/2013 | US8592181 Brazzein variant having higher sweetness and method for preparing multi-variant |
11/26/2013 | US8592178 Process for the preparation of testosterone |
11/26/2013 | US8592161 Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance |
11/26/2013 | US8592155 Method of detecting genetic deletions identified with chromosomal abnormalities |
11/26/2013 | US8592144 Beta-sheet proteins with specific binding properties |
11/26/2013 | US8592143 Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
11/26/2013 | US8591953 Drug carrier and drug carrier kit for inhibiting fibrosis |
11/26/2013 | US8591951 Tri-block copolymers for nanosphere-based drug delivery |
11/26/2013 | US8591915 Plant-derived vaccines against respiratory syncytial virus |
11/26/2013 | US8591910 Chemically programmable immunity |
11/26/2013 | US8591909 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
11/26/2013 | US8591896 Chemokine receptor binding polypeptides |
11/26/2013 | US8591894 Humanized antibodies that sequester amyloid beta peptide |
11/26/2013 | US8591879 Recombinant adenovirus vector having a reduced side effect |
11/26/2013 | CA2718802C Recombinant nucleic acids comprising regions of ad6 |
11/26/2013 | CA2618374C Trimeric collagen scaffold antibodies |
11/26/2013 | CA2573986C Transcription termination sequence and use thereof |
11/26/2013 | CA2539996C Prevention of incorporation of non-standard amino acids into protein |
11/26/2013 | CA2450828C Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
11/26/2013 | CA2450710C Methods for the simultaneous detection of hcv antigens and hcv antibodies |
11/26/2013 | CA2448971C Chimeric flavivirus vectors |
11/26/2013 | CA2425072C Wt1 fusion polypeptides and methods for wt1 immunotherapy |
11/26/2013 | CA2417986C Single-labeled oligonucleotide probes |
11/26/2013 | CA2378562C Method for producing oligopolysaccharides |
11/26/2013 | CA2334850C Novel methods and interferon deficient substrates for the propagation of viruses |
11/26/2013 | CA2279231C Activity dependent neurotrophic factor iii (adnf iii) |
11/26/2013 | CA2221690C Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
11/21/2013 | WO2013173761A2 St2 antigen binding proteins |
11/21/2013 | WO2013173714A2 Conversion of cardiomyocytes into fast conducting cardiomyocytes or slow conducting nodal cells |
11/21/2013 | WO2013173711A1 Bacterial mutants with improved transformation efficiency |
11/21/2013 | WO2013173702A2 Subfamily e simian adenoviruses a1302, a1320, a1331 and a1337 and uses thereof |
11/21/2013 | WO2013173652A1 Compositions and methods for modulating gene expression |
11/21/2013 | WO2013173645A1 Compositions and methods for modulating utrn expression |
11/21/2013 | WO2013173638A1 Compositions and methods for modulating smn gene family expression |
11/21/2013 | WO2013173637A1 Compositions and methods for modulating gene expression |
11/21/2013 | WO2013173635A1 Compositions and methods for modulating gene expression |
11/21/2013 | WO2013173608A1 Compositions and methods for modulating mecp2 expression |
11/21/2013 | WO2013173605A1 Compositions and methods for modulating pten expression |
11/21/2013 | WO2013173599A1 Compositions and methods for modulating hemoglobin gene family expression |
11/21/2013 | WO2013173598A1 Compositions and methods for modulating atp2a2 expression |
11/21/2013 | WO2013173535A2 Inducible promoter sequences for regulated expression and methods of use |
11/21/2013 | WO2013173512A2 High-transduction-efficiency raav vectors, compositions, and methods of use |
11/21/2013 | WO2013173345A1 Biosensors |
11/21/2013 | WO2013172964A1 Methods and compositions for treating amyloid deposits |
11/21/2013 | WO2013172782A1 A polyketide synthase construct and its use in the preparation of polyketides |
11/21/2013 | WO2013172579A1 Nanoprobe, and method for detecting target material using same |
11/21/2013 | WO2013172421A1 Ampk protein activator screening method, and ampk protein activator |
11/21/2013 | WO2013172379A1 Novel antibody and application thereof |